VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_24-vv-00632
Package ID: USCOURTS-cofc-1_24-vv-00632
Petitioner: William Mayfield
Filed: 2024-04-22
Decided: 2025-12-05
Vaccine: pneumococcal conjugate vaccine
Vaccination date: 2023-04-07
Condition: Shoulder Injury Related to Vaccine Administration (SIRVA)
Outcome: compensated
Award amount USD: 101656.75

AI-assisted case summary:
On April 22, 2024, William Mayfield filed a petition alleging that a pneumococcal conjugate vaccine administered on April 7, 2023 caused a shoulder injury related to vaccine administration. The public stipulation identifies him as an adult but does not state an exact age.

Respondent denied that the alleged SIRVA or its residual effects were caused by the pneumococcal conjugate vaccine and denied that the vaccine caused any other injury or current condition. The public decision does not describe symptom onset, treatment, imaging, injections, physical therapy, or expert opinions. On December 5, 2025, Chief Special Master Corcoran adopted the parties' stipulation and awarded $101,656.75 as a lump sum through counsel for all damages available under the Vaccine Act.

Theory of causation field:
Adult petitioner; pneumococcal conjugate vaccine April 7, 2023; alleged SIRVA. COMPENSATED by stipulation. Respondent denied causation; public text lacks clinical chronology. Decision December 5, 2025. Award $101,656.75 lump sum. Petition filed April 22, 2024.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_24-vv-00632-0
Date issued/filed: 2026-01-16
Pages: 7
Docket text: PUBLIC DECISION (Originally filed: 12/05/2025) regarding 25 DECISION Stipulation/Proffer. Signed by Chief Special Master Brian H. Corcoran. (cr) Service on parties made.
--------------------------------------------------------------------------------
Case 1:24-vv-00632-UNJ Document 30 Filed 01/16/26 Page 1 of 7
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 24-632V
WILLIAM MAYFIELD, Chief Special Master Corcoran
Petitioner,
v. Filed: December 5, 2025
SECRETARY OF HEALTH AND
HUMAN SERVICES,
Respondent.
Joseph P. Shannon, Shannon Law Group, P.C., Woodridge, IL, for Petitioner.
Emilie Williams, U.S. Department of Justice, Washington, DC, for Respondent.
DECISION ON JOINT STIPULATION1
On April 22, 2024, William Mayfield filed a petition for compensation under the
National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.2 (the
“Vaccine Act”). On April 7, 2023, Petitioner received a pneumococcal conjugate vaccine,
a vaccine contained in the Vaccine Injury Table (the “Table”), 42 C.F.R. § 100.3(a).
Petitioner alleges that he sustained a shoulder injury related to vaccine administration
(“SIRVA”) as defined in the Table; he further alleges that the vaccine caused his alleged
shoulder injury, and that he suffered the residual effects of his alleged injury for more than
six months.
Respondent denies that Petitioner’s alleged SIRVA or its residual effects were
caused-in-fact by the pneumococcal conjugate vaccine; and denies that the
pneumococcal conjugate vaccine caused Petitioner any other injury or his current
condition.
1 Because this Decision contains a reasoned explanation for the action taken in this case, it must be made
publicly accessible and will be posted on the United States Court of Federal Claims' website, and/or
at https://www.govinfo.gov/app/collection/uscourts/national/cofc, in accordance with the E-Government
Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government
Services). This means the Decision will be available to anyone with access to the internet. In
accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other
information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I
agree that the identified material fits within this definition, I will redact such material from public access.
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease
of citation, all section references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. §
300aa (2018).

Case 1:24-vv-00632-UNJ Document 30 Filed 01/16/26 Page 2 of 7
Nevertheless, on December 5, 2025, the parties filed the attached joint stipulation,
stating that a decision should be entered awarding compensation. I find the stipulation
reasonable and adopt it as my decision awarding damages, on the terms set forth therein.
Pursuant to the terms stated in the attached Stipulation, I award the following
compensation:
A lump sum of $101,656.75 to be paid through an ACH deposit to Petitioner’s
counsel’s IOLTA account for prompt disbursement to Petitioner. Stipulation
¶ 8. This amount represents compensation for all items of damages that would be
available under Section 15(a). Id.
I approve the requested amount for Petitioner’s compensation. In the absence of
a motion for review filed pursuant to RCFC Appendix B, the Clerk of Court is directed to
enter judgment in accordance with this decision.3
IT IS SO ORDERED.
s/Brian H. Corcoran
Brian H. Corcoran
Chief Special Master
3 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by the parties’ joint filing of notice
renouncing the right to seek review.
2

Case 1:24-vv-00632-UNJ Document 30 Filed 01/16/26 Page 3 of 7
IN THE UNITED STATES COURT OF FEDERAL CLAIMS
OFFICE OF SPECIAL MASTERS
WILLIAM MAYFIELD,
Petitioner, No. 24-632V
Chief Special Master Corcoran
v. ECF
SECRETA RY OF HEALTH AND
HUMAN SERVICES,
Respondent.
STIPULATION
The parties hereby stipulate to the following matters:
l. William Mayfield ("petitioner") filed a petition for vaccine compensation under the
National Vaccine Injury Compensation Program, 42 U.S.C. § 300aa-10 to 34 (the "Vaccine
Program"). The petition seeks compensation for injuries allegedly related to petitioner's receipt
of a pneumococcal conjugate vaccine, which vaccine is contained in the Vaccine Injury Table
(the "Table"), 42 C.F.R. § 100.3(a)
2. Petitioner received a pneumococcal conjugate vaccine on April 7, 2023.
3. The vaccine was administered within the United States.
4. Petitioner alleges that he suffered a Table Shoulder Injury Related to Vaccine
Administration ("SIRVA") that was caused by the pneumococcal conjugate vaccine. Petitioner
further alleges that he suffered the residual effects of the alleged injury for more than six months.
5. Petitioner represents that there has been no prior award or settlement of a civil action
for damages on petitioner's behalf as a result of the alleged injury.
':NV237 46794-74 36-BABB-8029-ACAF
12/02/202518:19 PM UTC

Case 1:24-vv-00632-UNJ Document 30 Filed 01/16/26 Page 4 of 7
6. Respondent denies that petitioner's alleged SIRVA or its residual effects were
caused-in-fact by the pneumococcal conjugate vaccine; and denies that the pneumococcal
conjugate vaccine caused petitioner any other injury or petitioner's current condition.
7. Maintaining their above-stated positions, the parties nevertheless now agree that the
issues between them shall be settled and that a decision should be entered awarding the
compensation described in paragraph 8 of this Stipulation.
8. As soon as practicable after an entry ofj udgment reflecting a decision consistent with
the terms of this Stipulation, and after petitioner has filed an election to receive compensation
pursuant to 42 U.S.C. § 300aa-2l(a)(l), the Secretary of Health and Human Services will issue
the following vaccine compensation payment for all damages that would be available under 42
U.S.C. § 300aa-15(a):
A lump sum of $101,656.75 to be paid through an ACH deposit to petitioner's
counsel's JOLTA account for prompt disbursement to petitioner. This amount
represents compensation for all damages that would be available under 42 U.S.C.
§ 300aa-15(a).
9. As soon as practicable after the entry ofj udgment on entitlement in this case, and after
petitioner has filed both a proper and timely election to receive compensation pursuant to 42
U.S.C. § 300aa-21(a)(l), and an application, the parties will submit to further proceedings before
the special master to award reasonable attorneys' fees and costs incurred in proceeding upon this
petition.
10. Petitioner and petitioner's attorney represent that compensation to be provided
pursuant to this Stipulation is not for any items or services for which the Program is not
primarily liable under 42 U.S.C. § 300aa-l 5(g), to the extent that payment has been made or can
reasonably be expected to be made under any State compensation programs, insurance policies,
2
=NV237 46794-74 36-BABB-8029-ACAF
12/02/2025 18:19 PM UTC

Case 1:24-vv-00632-UNJ Document 30 Filed 01/16/26 Page 5 of 7
Federal or State health benefits programs (other than Title XIX of the Social Security Act (42
U.S.C. § 1396 et seq.)), or by entities that provide health services on a pre-paid basis.
11. Payments made pursuant to paragraph 8 and any amounts awarded pursuant to
paragraph 9 of this Stipulation will be made in accordance with 42 U.S.C. § 300aa-15(i), subject
to the availability of sufficient statutory funds.
12. The parties and their attorneys further agree and stipulate that, except for any award
for attorney's fees and litigation costs, and past unreimbursed expenses, the money provided
pursuant to this Stipulation will be used solely for the benefit of petitioner as contemplated by a
strict construction of 42 U.S.C. § 300aa-l 5(a) and (d), and subject to the conditions of 42 U.S.C.
§ 300aa-l 5(g) and (h).
13. In return for the payments described in paragraphs 8 and 9, petitioner, in petitioner's
individual capacity, and on behalf of petitioner's heirs, executors, administrators, successors or
assigns, does forever irrevocably and unconditionally release, acquit and discharge the United
States and the Secretary of Health and Human Services from any and all actions or causes of
action (including agreements, judgments, claims, damages, loss of services, expenses and all
demands of whatever kind or nature) that have been brought, could have been brought, or could
be timely brought in the Court of Federal Claims, under the National Vaccine Injury
Compensation Program, 42 U.S.C. § 300aa-l O et seq., on account of, or in any way growing out
of, any and all known or unknown, suspected or unsuspected personal injuries to or death of
petitioner resulting from, or alleged to have resulted from, the pneumococcal conjugate
vaccination administered on April 7, 2023, as alleged in a petition for vaccine compensation filed
on or about April 22, 2024, in the United States Court of Federal Claims as petition No. 24-
632V.
3
=NV23 74 6794-7 436-BABB-8029-ACAF
12/02/2025 18:19 PM UTC

Case 1:24-vv-00632-UNJ Document 30 Filed 01/16/26 Page 6 of 7
14. If petitioner should die prior to entry of judgment, this agreement shall be voidable
upon proper notice to the Court on behalf of either or both of the parties.
15. If the special master fails to issue a decision in complete conformity with the terms
of this Stipulation or if the Court of Federal Claims fails to enter judgment in conformity with a
decision that is in complete conformity with the terms of this Stipulation, then the parties'
settlement and this Stipulation shall be voidable at the sole discretion of either party.
16. This Stipulation expresses a full and complete negotiated settlement of liability and
damages claimed under the National Childhood Vaccine Injury Act of 1986, as amended, except
as otherwise noted in paragraph 9 above. There is absolutely no agreement on the part of the
parties hereto to make any payment or to do any act or thing other than is herein expressly stated
and clearly agreed to. The parties further agree and understand that the award described in this
Stipulation may reflect a compromise of the parties' respective positions as to liability and/or
amount of damages, and further, that a change in the nature of the injury or condition or in the
items of compensation sought, is not grounds to modify or revise this agreement.
17. This Stipulation shall not be construed as an admission by the United States or the
Secretary of Health and Human Services that the pneumococcal conjugate vaccine caused
petitioner's alleged injury or any other injury or petitioner's current disabilities.
18. All rights and obligations of petitioner hereunder shall apply equally to petitioner's
heirs, executors, administrators, successors, and/or assigns.
END OF STIPULATION
I
I
I
4
::NV2374 6794-74 36-BABB-8029-ACAF
12/02/2025 18:19 PM UTC

Case 1:24-vv-00632-UNJ Document 30 Filed 01/16/26 Page 7 of 7
Respectfully submitted,
PETITIONER:
WILLIAM MAYFIELD
ATTORNEY OF RECORD FOR AUTHORIZED REPRESENTATIVE
ETITIONER: OF THE ATTORNEY GENERAL:
~w~
HEATHER L. PEARLMAN
on Law Group, P.C. Deputy Director
Hobson Valley Dr., Ste. 101 Torts Branch
oodridge, Illinois 60517 Civil Division
(312) 578-9501 U.S. Department of Justice
joseph@shannonlawgroup.com P.O. Box 146
Benjamin Franklin Station
Washington, DC 20044-0146
AUTHORIZED REPRESENTATIVE ATTORNEY OF RECORD FOR
OF THE SECRETARY OF HEALTH RESPONDENT:
AND HUMAN SERVICES:
Jeffrey S. Digitally signed by Jeffrey
S. Beach-S
-S f
Beach Date:2025.11.2111:28:23
-os·oo· or
CAPT GEORGE REED GRIMES, MD, MPH
Director, Division oflnjury Trial Attorney
Compensation Programs Torts Branch
Health Systems Bureau Civil Division
Health Resources and Services U.S. Department of Justice
Administration P.O. Box 146
U.S. Department of Health Benjamin Franklin Station
and Human Services Washington, DC 20044-0146
5600 Fishers Lane, 14W-18 (202) 305-0124
Rockville, MD 20857 emilie. williams@usdoj.gov
Y2 • S· ?...£
Dated:
---~--cc..__ _
5
~NV2374 6794-74 36-BABB-8029-ACAF
12/02/2025 18:19 PM UTC